Vanguard Total International Stock ETF
VXUS · NASDAQ · US registered open-end fund · Global ex-US equity · Trading currency USD · Fund domicile United States
An excellent fund inside the wrong wrapper. VXUS holds 8,755 non-US stocks for five basis points and has tracked its index to within two basis points a year for a decade. For a Bahrain-resident holder it also carries roughly sixty-nine basis points of unrecoverable US withholding tax and a forty percent estate tax exposure above sixty thousand dollars. The portfolio is not the problem. The domicile is.
AVOID is assigned on structure, not quality. The wrapper costs roughly fourteen times the management fee: on the portfolio's 2.3% equity yield, US withholding at the statutory 30% non-treaty rate removes about 0.69% a year, against an expense ratio of 0.05%. An Irish or Luxembourg fund holding the same non-US equities pays no second layer.
The role, the horizon, the band
Role. Single-instrument core exposure to every listed equity market outside the United States, developed and emerging, large through small cap. It is a completion holding sitting alongside a US sleeve, not a standalone portfolio.
Holding period. Ten years or longer. Nothing shorter justifies a broad market-cap index, and nothing shorter lets the cost arithmetic matter either way.
Allocation band. Liquidity and diversification impose no constraint: 8,755 holdings, $156.5bn of ETF assets, roughly $518m traded daily. The binding constraint is the US estate tax filing threshold. At $86.51 a share, about 690 shares takes a Bahrain-resident estate past $60,000 of US-situs assets. Any position large enough to matter as a core holding is a position large enough to create the exposure.
| Item | Status |
|---|---|
| Registered fund, not a note | Confirmed |
| Issuer credit risk | None |
| Leverage or daily reset | None |
| Synthetic replication | None |
| Shariah screening | None applied |
| US-situs asset | Yes |
VXUS is an ETF share class of the Vanguard Total International Stock Index Fund, a US registered investment company. It invests substantially all assets in the common stocks of its target index and remains fully invested. Short-term reserves were 0.0% at 30 June 2026.
Three reasons to own it
- Cost. 0.05% against a 0.87% category average and a 0.38% average for ETFs in the category.
- Tracking. Average tracking difference of about two basis points a year across the ten calendar years 2016 to 2025, better than the expense ratio implies.
- Breadth. 8,755 stocks against 3,858 in VEU and 4,337 in IXUS, with 26.4% in emerging markets and genuine small-cap reach.
Three risks that matter
- The wrapper. 30% US withholding on distributions with no Bahrain treaty, plus estate tax at rates up to 40% above the $60,000 threshold.
- Concentration. Three Asian semiconductor names are 9.1% of the fund. Taiwan and Korea together are 16.6%.
- The discount is earned. 18.3x earnings against 27.0x for the US total market, but return on equity of 13.3% against 24.7%.
The wrapper costs roughly fourteen times the management fee. On the portfolio's 2.3% equity yield, US withholding at the statutory 30% non-treaty rate removes about 0.69% a year, against an expense ratio of 0.05%. An Irish or Luxembourg fund holding the same non-US equities pays no second layer. That difference is structural, recurring, and larger than any fee decision available inside the category.
Objective, index methodology and structure
VXUS seeks to track the FTSE Global All Cap ex US Index, a float-adjusted market-capitalisation index covering large, mid and small cap stocks in developed and emerging markets outside the United States. Vanguard states the index covers 98% of the world's non-US markets across the European, Pacific, emerging market and North American regions, with Japan, the United Kingdom, Canada, Australia and France the largest constituent markets.
The mandate is passive and unconditional. There is no screen, no tilt, no optimisation away from the benchmark, and no discretion over country or sector weights: the fund allocates on each region's index weighting and remains fully invested. Sector deviations at 30 June 2026 were 0.3 percentage points at the widest, in Technology, and zero across seven of the eleven sectors. That is the intended behaviour of the vehicle, and it is the reason the assessment framework here is cost, tracking and structure rather than security selection.
Assessment framework, and why
This is a broad-market index tracker, so the framework applied is total cost of ownership plus tracking quality, judged against the peer set doing the same job. The index determines the return; the vehicle determines how much of that return the holder keeps. No discounted cash flow, no earnings multiple target and no per-share fair value is applied, because a fund has no cash flows, earnings or intrinsic value of its own. Where a valuation judgement is needed it is made on a look-through basis against what the fund holds, in section 05.
| Item | Value |
|---|---|
| Legal structure | US registered open-end fund |
| Share class | ETF class of index fund |
| Inception | 26 January 2011 |
| Exchange | NASDAQ |
| CUSIP | 921909768 |
| Index ticker | TGPVAN17 |
| Distribution | Quarterly, distributing |
| Turnover, fiscal year | 4.4% |
| Short-term reserves | 0.0% |
| Metric | VXUS | Index |
|---|---|---|
| Number of stocks | 8,755 | 8,579 |
| Median market cap | $57.1bn | $57.0bn |
| Average market cap | $236.8bn | $232.2bn |
| Price / earnings | 18.3x | 18.2x |
| Price / book | 2.3x | 2.3x |
| Return on equity | 13.3% | 13.3% |
| Earnings growth rate | 12.6% | 12.5% |
| Equity yield | 2.3% | 2.3% |
| Standard deviation, 3y | 12.90% | 13.92% |
Source: Vanguard Total International Stock ETF fact sheet and investment profile, as of 30 June 2026.
Fund versus note, leverage, replication
VXUS is a registered fund holding the underlying securities directly, not an exchange traded note. There is no unsecured obligation of an issuing bank in the structure and therefore no issuer credit risk beyond ordinary custody arrangements. There is no leverage, no daily reset and no synthetic replication. Where a product carries any of those features it outranks every other consideration in an assessment; none applies here, and the structure is as plain as the category offers.
What the index does not screen for
The methodology applies no ethical, sustainability or Shariah filter. Financials were 22.2% of the fund at 30 June 2026, the largest single sector, and the index includes conventional banks, insurers and leveraged industrials without a debt-ratio or income-purity test. For a portfolio operating a Shariah-screened core, VXUS is not a candidate for the core sleeve on any reading. The Islamic UCITS range covers developed world, emerging markets, the United States and, since Invesco's February 2026 launch, all-world including emerging markets. It does not currently offer a global ex-US mandate, so this exposure has no screened single-fund equivalent.
Nothing about the index rules or the fund structure argues against VXUS. The methodology is the most complete ex-US index available in a single instrument, and the implementation is faithful to it. Every reservation in this note arises after the portfolio, at the level of the wrapper.
Holdings, concentration and currency
| Holding | Market | % |
|---|---|---|
| Taiwan Semiconductor Manufacturing | Taiwan | 4.3 |
| Samsung Electronics | Korea | 2.6 |
| SK hynix | Korea | 2.2 |
| ASML Holding | Netherlands | 1.7 |
| Tencent Holdings | China | 0.8 |
| HSBC Holdings | United Kingdom | 0.7 |
| Roche Holding | Switzerland | 0.7 |
| Novartis | Switzerland | 0.7 |
| Royal Bank of Canada | Canada | 0.7 |
| AstraZeneca | United Kingdom | 0.6 |
| Top ten | 15.0 |
Source: Vanguard investment profile, 30 June 2026. Holdings exclude temporary cash and equity index products. The three shaded holdings above (TSMC, Samsung, SK hynix) together carry 9.1% of the fund, more than the entire Utilities and Real Estate sectors combined.
Source: Vanguard investment profile, 30 June 2026. Sectors on the ICB classification.
Source: Vanguard investment profile, 30 June 2026.
| Region | Weight | Largest market |
|---|---|---|
| Europe | 35.9% | United Kingdom 8.0% |
| Pacific | 29.1% | Japan 15.4% |
| Emerging markets | 26.4% | Taiwan 9.1% |
| North America | 7.7% | Canada 7.7% |
| Middle East and other | 0.8% |
FTSE classifies Korea as developed, which places its 7.5% weight in Pacific rather than emerging markets. On the MSCI convention used by IXUS, the emerging weight would be closer to 34%. Two funds described as global ex-US can differ by eight percentage points of emerging exposure purely on this classification.
Currency exposure of the holdings, which is not the trading currency
VXUS trades in US dollars on NASDAQ and reports in US dollars. It holds no US assets. The dollar is a translation layer, not an exposure: the risk currencies are the yen at 15.4%, the Taiwan dollar at 9.1%, sterling at 8.0%, the Canadian dollar at 7.7%, the Korean won at 7.5%, and at least 16.9% across the named eurozone markets of France, Germany, the Netherlands, Spain and Italy before the 3.9% unallocated to other European markets. Nothing is hedged.
For a Bahrain-based holder this is the same exposure it would be for a US holder, because the Central Bank of Bahrain maintains the dinar at a fixed 0.376 to the dollar and has done so since 1980. Dollar strength and weakness pass through to a BHD-reporting portfolio essentially one for one. Currency is a genuine driver of this fund's return and it is quantified in the scenario table in section 05.
The cost stack and the tax wrapper
The management fee is the smallest cost in this holding and the easiest to see. The largest is invisible on any factsheet, arrives net of tax in the distribution, and is unrecoverable.
| Layer | Cost p.a. | Recoverable |
|---|---|---|
| Expense ratio | 0.05% | No |
| Tracking difference, 10y average | +0.02% | Credit |
| US withholding on distributions | 0.69% | No |
| Source-country withholding | Level 1 | No |
| Visible plus withholding | 0.74% |
The withholding line is our own arithmetic: the statutory 30% non-treaty rate applied to the fund's 2.3% equity yield. Source-country withholding is suffered under any domicile and is not additive to the comparison below, because it applies to the alternatives as well.
Own arithmetic; see cost stack table. Against the category, VXUS is close to free. Against its own tax wrapper, the fee is a rounding error. Both statements are true and only the second one changes a decision.
Two layers of withholding, and where they differ
Every fund holding Japanese, French or Taiwanese equities suffers withholding in those markets at rates set by the fund domicile's own treaty network. That is level one, and it applies to a US fund and an Irish fund alike. Level two is where the structures separate. State Street Global Advisors states that for non-US investors holding US-domiciled ETFs, dividends distributed from the fund are generally subject to a 30% withholding tax unless reduced under an applicable treaty, while for Irish UCITS the withholding is applied at investment level only.
The IRS list of United States income tax treaties runs from Armenia to Venezuela and does not include Bahrain. There is no reduced rate to claim and no Form W-8BEN election that improves the position. Nor is there an offsetting benefit: the foreign tax credits a US fund passes through are worth nothing to a holder with no US tax liability to credit them against.
Shares in a US corporation, including shares of a US registered fund, are US-situs property in the estate of a nonresident who is not a US citizen, regardless of where the brokerage account sits. The IRS requires Form 706-NA where US-situated assets exceed $60,000, a threshold that is not indexed for inflation, and the unified credit available to a nonresident is $13,000, sheltering exactly that $60,000. Above it, the unified rate schedule runs from 18% to 40%. The Form 706-NA instructions list treaty relief for Australia, Canada, Finland, France, Germany, Greece, Italy, Japan and Switzerland. Bahrain is not among them. At $86.51 a share, roughly 690 shares crosses the threshold.
| Item | US fund | Irish or Luxembourg UCITS |
|---|---|---|
| Expense ratio, ex-US mandate | 0.05% | 0.09% to 0.15% |
| Level 2 withholding on distributions | 30% | None |
| Drag on a 2.3% yield | 0.69% | 0.00% |
| US-situs for estate tax | Yes | No |
| Accumulating share class available | No | Yes |
| Net structural advantage | ~0.59% p.a. |
Net advantage is 0.69% of withholding avoided less 0.10% of additional expense ratio at the 0.15% Irish funds, our own arithmetic. The usual reason to prefer Irish over Luxembourg domicile is the 15% treaty rate on US dividends, and a fund that holds no US equities does not benefit from it. For this specific exposure, Luxembourg domicile is not the disadvantage it would be in a global or US mandate: both sit outside US situs. Confirm actual treatment against broker statements before acting; the figure that matters is the one on the distribution advice rather than the statutory rate.
Fund quality, liquidity and tracking
Judged as an index-tracking machine and nothing else, VXUS is among the best-executed products in the global fund industry. This section makes that case with the numbers, because the rating is not a criticism of the fund and the distinction has to be earned rather than asserted.
The benchmark is a spliced series adjusted for withholding taxes, so this is a like-for-like net comparison. Average across 2016 to 2025 is minus 0.016 points a year, against a 0.05% expense ratio.
ETF class assets have grown from $6.4bn at the end of 2016 to $156.5bn at 30 June 2026. Scale of this order removes any realistic question of fund closure, creation-unit friction or forced liquidation at a bad moment.
Performance against index and against the category
| Annualised to 30 Jun 2026 | Quarter | 1 year | 3 years | 5 years | 10 years | Since inception |
|---|---|---|---|---|---|---|
| VXUS, net asset value | 12.01% | 27.42% | 18.73% | 8.81% | 9.97% | 6.68% |
| VXUS, market price | 11.36% | 27.31% | 18.66% | 8.77% | 9.95% | 6.68% |
| Spliced benchmark | 13.57% | 26.74% | 18.60% | 8.67% | 9.97% | 6.66% |
| International multi-cap core average | 9.86% | 22.81% | 17.73% | 9.09% | 9.36% | — |
Source: Vanguard investment profile, 30 June 2026. Periods under one year are cumulative; all others annualised. Returns are net of expenses and assume reinvestment.
Over ten years the fund returned exactly what its index returned, 9.97% against 9.97%, after fees. That is the whole argument for indexing delivered in one line. Against the peer group the fund is ahead over one, three and ten years and behind over five, 8.81% against 9.09%, which is the single performance figure a bull case should have to answer rather than skip.
| Item | Value |
|---|---|
| Last close, 5 Aug 2026 | $86.51 |
| Net asset value | $86.37 |
| Premium to NAV | +0.16% |
| 52-week range | $69.94 to $88.62 |
| Average daily volume | 5.99m shares |
| Beta to benchmark, 3y | 0.91 |
| R-squared to benchmark, 3y | 0.97 |
Premium and daily traded value are our own calculations from the closing price, NAV and average volume shown.
| Ex-date | Per share |
|---|---|
| 18 June 2026 | $0.39 |
| 20 March 2026 | $0.08 |
| 19 December 2025 | $1.36 |
| 19 September 2025 | $0.36 |
| Trailing twelve months | $2.19 |
$2.19 on a $86.51 close is a 2.53% trailing distribution yield, our own calculation. Distributions are heavily weighted to December, which matters for anyone timing a purchase around an ex-date they will be taxed on at 30%.
Return drivers, look-through valuation and scenarios
Both figures below come from the same provider, on the same date, on the same methodology, which is the only way this comparison is worth making. The ex-US market trades at a wide discount to the US market on every multiple. It also earns roughly half the return on equity.
| Metric | VXUS | VTI | Gap |
|---|---|---|---|
| Price / earnings | 18.3x | 27.0x | -32% |
| Price / book | 2.3x | 4.9x | -53% |
| Return on equity | 13.3% | 24.7% | -46% |
| Earnings growth rate | 12.6% | 21.9% | -42% |
| Standard deviation, 3y | 12.90% | 13.45% | — |
A 53% discount on book value against a 46% deficit in return on equity is close to arithmetic consistency, not a mispricing. The honest reading of the international valuation discount is that most of it is paid for.
Source: Vanguard investment profile, 30 June 2026, for both funds.
Where the last twelve months of return came from
The benchmark returned 26.74% in the year to 30 June 2026. Technology contributed most at 73.1%, with financials at 25.9% and industrials at 19.6%. In the June quarter those three sectors carried 57.0% of index weight and added about 11.6 points of the 13.57% result, energy the sole detractor at minus 9.1%. Over that quarter the benchmark still trailed the Russell 3000's 15.45%. A year of exceptional return has come from a narrow group of sectors, with the semiconductor names in section 02 at the centre of it. Extrapolating it forward would be an error.
Ten-year scenarios, built from components rather than a target price
| Component, % p.a. | Bear | Base | Bull | Assumption behind it |
|---|---|---|---|---|
| Earnings growth | 3.0 | 5.5 | 7.0 | Sustainable growth is 7.7% (57.9% retention on 13.3% ROE); base haircuts for dilution and reinvestment slippage |
| Dividend yield | 2.3 | 2.3 | 2.3 | Current portfolio equity yield held flat |
| Valuation change | -2.6 | 0.0 | +1.4 | Bear derates 18.3x to 14x, bull rerates to 21x, both over ten years |
| Currency | -1.0 | 0.0 | +1.0 | Dollar trend against an unhedged non-USD book |
| Expense ratio | -0.05 | -0.05 | -0.05 | Prospectus rate held constant |
| US withholding | -0.69 | -0.69 | -0.69 | 30% statutory rate on the 2.3% yield, no treaty |
| Annualised total return | 0.9 | 7.1 | 11.0 | Probability 25 / 50 / 25 |
| Same exposure, UCITS wrapper | 1.5 | 7.7 | 11.6 | Withholding removed, expense ratio at 0.15% |
Estimates, not facts, and every one of them is ours. Probability-weighted expected return is 6.5% a year in the US wrapper against 7.1% in a UCITS wrapper on identical portfolio assumptions. The 0.59 point gap is the only line in this table that does not depend on a forecast.
Vertical marker = current price % 7.1
Built from the ten-year scenario table above. The vertical marker is the US-wrapper base case; the UCITS-wrapper base case is 7.7% p.a., 0.6 points higher, on identical portfolio assumptions.
| Distribution yield | 1.5% | 2.0% | 2.3% | 2.8% | 3.3% |
|---|---|---|---|---|---|
| Withholding drag at 30% | 0.45 | 0.60 | 0.69 | 0.84 | 0.99 |
| Multiple of the 0.05% fee | 9x | 12x | 14x | 17x | 20x |
Our own arithmetic; the current 2.3% portfolio equity yield is the shaded case. The drag scales directly with the yield, so it grows precisely when the fund does the thing income investors buy it for.
Argue with the growth rate, argue with the derating, argue with the currency path. Every one of those arguments moves both wrappers by the same amount. The wrapper difference survives every scenario in the table, and compounded over a twenty-year holding period a 0.59 point annual gap costs roughly eleven percent of terminal wealth.
Peer vehicles, risk register and the case both ways
| Fund | Domicile | Index | Fee | Size | US situs |
|---|---|---|---|---|---|
| Vanguard Total International Stock (VXUS) | United States | FTSE Global All Cap ex US | 0.05% | $156.5bn | Yes |
| Vanguard FTSE All-World ex-US (VEU) | United States | FTSE All-World ex US | 0.04% | $67.3bn | Yes |
| iShares Core MSCI Total International (IXUS) | United States | MSCI ACWI ex USA IMI | 0.07% | $58.5bn | Yes |
| Xtrackers MSCI World ex USA 1C | Ireland | MSCI World ex USA | 0.15% | €6.4bn | No |
| iShares MSCI World ex-USA USD Acc | Ireland | MSCI World ex USA | 0.15% | €3.1bn | No |
| Amundi MSCI World ex USA Acc | Ireland | MSCI World ex USA | 0.15% | €0.7bn | No |
| UBS MSCI World ex USA USD Acc | Luxembourg | MSCI World ex USA | 0.09% | €0.4bn | No |
Sources: Vanguard and iShares fact sheets at 30 June 2026; justETF as of 5 August 2026 for UCITS fee, size and domicile.
The peer set is not like for like, and saying so is the point. No UCITS fund replicates the FTSE Global All Cap ex US mandate. Every European alternative above tracks MSCI World ex USA: developed markets only, large and mid cap only. Substituting drops the 26.4% emerging weight and the small-cap tail, and needs a separate emerging sleeve to restore the mandate. That is the real cost of leaving the US wrapper, and it is operational rather than a fee.
The case for owning it
- The most complete non-US equity index in one instrument, 8,755 holdings against 3,858 in VEU and 4,337 in IXUS.
- 0.05% against a 0.87% category average, with tracking averaging about two basis points a year for a decade.
- Ten-year return of 9.97% matched the index exactly and beat the 9.36% category average, on $156.5bn of ETF assets over a fifteen-year record.
- Look-through valuation of 18.3x earnings and 2.3x book against 27.0x and 4.9x for the US total market.
- Emerging markets at 26.4% in one fund, which no UCITS ex-US alternative currently offers.
The case against, argued properly
- The wrapper removes about 0.69% a year and cannot be reclaimed, fourteen times the management fee.
- US-situs status puts the position inside a 40% estate tax regime above $60,000, with no Bahrain treaty relief.
- The valuation discount is largely explained by profitability: 13.3% return on equity against 24.7%.
- Five-year return of 8.81% trailed the 9.09% category average, so the cost edge has not always converted into performance.
- Diversification is less complete than 8,755 holdings implies: 9.1% in three semiconductor names, 16.6% in Taiwan and Korea.
- No Shariah screen, financials the largest sector at 22.2%.
| Risk | Mechanism | Quantified |
|---|---|---|
| Tax wrapper | 30% US withholding on distributions, no treaty available to a Bahrain resident | 0.69% p.a. |
| Estate tax | US-situs shares above the $60,000 Form 706-NA threshold, no treaty relief | Up to 40% |
| Concentration | Three Asian semiconductor manufacturers, one industry, two economies | 9.1% |
| Geopolitical | Taiwan and mainland China combined weight | 15.8% |
| Currency | Fully unhedged, no US assets, BHD pegged to USD at 0.376 | 100% non-USD |
| Narrow leadership | Technology returned 73.1% over twelve months and led the index result | 19.7% |
| Drawdown | Worst quarter and worst calendar year in the record | -24.3% / -16.0% |
| Mandate fit | No Shariah screen, financials largest sector | 22.2% |
Portfolio fit and drawdown tolerance
The exposure belongs in a diversified portfolio: non-US equities are a large share of global market capitalisation and omitting them is an active bet. This note answers only how to own it. Anyone holding VXUS should be able to absorb a 24.3% fall in a single quarter, which the first quarter of 2020 delivered, and a 15.99% calendar-year loss, which 2022 delivered. Neither is a forecast; both are in the fund's own record. If those numbers would force a sale, the position is too large whatever the wrapper.
The decision, monitoring and basis of analysis
AVOID is assigned on structure, not quality. VXUS passes every test this framework applies to a fund: cost, tracking, breadth, scale, provider, replication and index rules. It fails the one test a fund cannot fix from the inside, which is where it is domiciled relative to the person holding it. For a US taxpayer the same analysis produces a BUY, and that reversal is the clearest statement of what the rating means here.
Why AVOID rather than WATCH. A named substitute is available today: an Irish or Luxembourg domiciled MSCI World ex USA UCITS fund for the developed sleeve, paired with an emerging markets UCITS fund to restore the 26.4% the narrower index leaves out. That build costs more in fees and needs two positions, and still finishes roughly 0.59 points a year ahead on the section 05 arithmetic.
What would change the rating
- A United States and Bahrain income tax treaty entering force, reducing the 30% rate on distributions.
- A United States and Bahrain estate tax treaty, removing the situs exposure above $60,000.
- A UCITS fund launching on the FTSE Global All Cap ex US mandate or an equivalent all-cap ex-US index. That moves the rating to BUY on the new instrument, not on VXUS.
- Total US-situs holdings kept permanently below $60,000, which removes the estate exposure but leaves the 0.69% drag intact, so moves the rating no further than WATCH.
| Check | Frequency | Trigger for action |
|---|---|---|
| Total US-situs holdings across all accounts | Quarterly | Aggregate approaching $60,000 |
| Withholding actually applied on distribution advices | Each distribution | Rate differs from the 30% assumed here |
| Tracking difference against benchmark | Annually | Exceeds the expense ratio for two consecutive years |
| Top-ten weight and single-industry concentration | Semi-annually | Top ten above 20% or one industry above 12% |
| UCITS launch on an all-cap ex-US mandate | Annually | Any launch with scale and a credible provider |
Decision checklist
- Is the underlying exposure wanted at all
- Is the holder a US taxpayer
- Does a treaty reduce the 30% rate
- Will total US-situs assets exceed $60,000
- Is a UCITS route accessible through the broker
- Can two funds replace one without drift
- Is a 24% quarterly fall survivable
- Does a Shariah screen apply to this sleeve
| Rating | Meaning |
|---|---|
| BUY | Passes on cost, tracking, structure and scale, and is the preferred vehicle in the named peer set for the stated role |
| WATCH | Quality passes but a named trigger, price or disclosure must resolve first |
| AVOID | A named alternative is clearly better, or a structural feature makes it unsuitable for the stated role |
House convention maps these to BUY, HOLD and SELL. WATCH replaces HOLD because these notes inform a decision to buy rather than advise an existing position. A fund rating is meaningless without a stated role and a named peer set; both appear in sections 01 and 06.
Basis of analysis. Desk research completed 6 August 2026. Fund data from the Vanguard Total International Stock ETF fact sheet and investment profile, both as of 30 June 2026, and from the corresponding Vanguard documents for VEU and VTI. Peer data from the iShares Core MSCI Total International Stock ETF fact sheet as of 30 June 2026, and from justETF as of 5 August 2026 for UCITS domicile, fee and fund size. Tax treatment from the Internal Revenue Service pages on income tax treaties and on estate tax for nonresidents not citizens, the Instructions for Form 706-NA, and State Street Global Advisors on US-domiciled ETFs versus Irish UCITS for non-US investors. Currency regime from the Central Bank of Bahrain. Market and volume data from Yahoo Finance, 6 August 2026. Trailing distributions cross-checked against stockanalysis.com and slickcharts.com and reconciled to the Vanguard profile.
Limits. Desk research on public documents, with no access to management, the custodian or any broker statement. Fund data carries its own 30 June 2026 as-of date and will have moved. The withholding and estate tax treatment described is the statutory position from published guidance and is not tax advice. All forward figures in section 05 are our own estimates, derived from the printed assumptions beside them.
Analyst certification. The views expressed accurately reflect the analyst's personal views about the fund discussed. No part of any compensation was, is, or will be directly or indirectly related to the specific views expressed. No position is held in VXUS or in any fund named as an alternative at the date of this note.
This note does not take account of any particular person's objectives, financial situation, or needs. It is not tax or legal advice, and anyone relying on the tax discussion should obtain professional advice for their own circumstances. Past performance is not a guide to future returns.
This document is independent research prepared for informational purposes. It is not investment advice, not a recommendation to buy or sell any security, and does not constitute an offer or solicitation. Figures are drawn from public sources believed reliable as of the date shown and may change without notice. Anyone acting on this material does so at their own risk and should seek their own professional advice.